Clinical trials

  • CABA-201 for Idiopathic inflammatory myopathy|Dermatomyositis|Anti-synthetase syndrome|Immune-mediated necrotizing myopathy|Juvenile idiopathic inflammatory myopathy
  • Piperacillin; Tazobactam for Bacterial infection|Infectious disease
  • pembrolizumab for Metastatic non-small cell lung cancer (NSCLC)
  • DASATINIB for Asymptomatic HIV-1 infection
  • REPINATRABIT for Phenylketonuria
  • Cannabidiol for Head and neck squamous cell carcinoma | Head and Neck Cancer
  • Nilotinib for Chronic myeloid leukaemia (in remission)|Chronic myeloid leukaemia
  • Levosimendan for Heart failure with reduced ejection fraction (HFrEF)
  • Methylphenidate hydrochloride for Attention deficit hyperactivity disorder (ADHD) | Obesity
  • Dupilumab for Chronic rhinosinusitis with nasal polyps
  • VINORELBINE for Metastatic colorectal cancer
  • Trastuzumab for Metastatic breast cancer | HER3-mutant metastatic breast cancer | HER2-negative metastatic breast cancer